Cargando…

High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer

BACKGROUND: Sushi repeat-containing protein X-linked 2 (SRPX2) is overexpressed in a variety of different tumor tissues and correlated with poor prognosis in patients. Little research focuses on the role of SRPX2 expression in prostate cancer (PCa), and the clinicopathological significance of the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Meng, Li, Xiaoli, Fan, Zhirui, Zhao, Jing, Liu, Shuzheng, Zhang, Mingzhi, Li, Huixiang, Goscinski, Mariusz Adam, Fan, Huijie, Suo, Zhenhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983007/ https://www.ncbi.nlm.nih.gov/pubmed/29881288 http://dx.doi.org/10.2147/OTT.S158820

Ejemplares similares

Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer
por: Zhao, Jing, et al.
Publicado: (2020)

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
por: Li, Xiaoli, et al.
Publicado: (2016)

Anti-senescence role of heterozygous fumarate hydratase gene knockout in rat lung fibroblasts in vitro
por: Fan, Zhirui, et al.
Publicado: (2019)

Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers
por: Zhong, Yali, et al.
Publicado: (2017)

Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
por: Li, Xiaoli, et al.
Publicado: (2017)

Establishment of mitochondrial pyruvate carrier 1 (MPC1) gene knockout mice with preliminary gene function analyses
por: Li, Xiaoli, et al.
Publicado: (2016)

PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence
por: Li, Yaqing, et al.
Publicado: (2016)

Generation of an oxoglutarate dehydrogenase knockout rat model and the effect of a high-fat diet
por: Fan, Zhirui, et al.
Publicado: (2018)

Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas
por: Li, Yaqing, et al.
Publicado: (2016)

CD117 expression in operable oesophageal squamous cell carcinomas predicts worse clinical outcome
por: Fan, Huijie, et al.
Publicado: (2013)

SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer
por: Li, Hao, et al.
Publicado: (2019)

Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
por: Li, Xiaoran, et al.
Publicado: (2017)

ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro
por: Yu, Dandan, et al.
Publicado: (2015)

Generation of TALEN-mediated FH knockout rat model
por: Yu, Dandan, et al.
Publicado: (2016)

SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma
por: Ampudia-Mesias, Elisabet, et al.
Publicado: (2022)

SRPX2 Is a Novel Chondroitin Sulfate Proteoglycan That Is Overexpressed in Gastrointestinal Cancer
por: Tanaka, Kaoru, et al.
Publicado: (2012)

PDHA1 Gene Knockout In Human Esophageal Squamous Cancer Cells Resulted In Greater Warburg Effect And Aggressive Features In Vitro And In Vivo
por: Liu, Lan, et al.
Publicado: (2019)

CD117 Expression in Fibroblasts-Like Stromal Cells Indicates Unfavorable Clinical Outcomes in Ovarian Carcinoma Patients
por: Huang, Ruixia, et al.
Publicado: (2014)

SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway
por: Wu, Zhiqiang, et al.
Publicado: (2020)

SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
por: Gao, Zhenyuan, et al.
Publicado: (2020)

SRPX2 Promotes Tumor Proliferation and Migration via the FAK Pathway in Papillary Thyroid Carcinoma
por: Luo, Ning, et al.
Publicado: (2022)

Promoting role of pentraxin-3 in esophageal squamous cell carcinoma
por: Fan, Zhirui, et al.
Publicado: (2022)

Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model
por: Fan, Zhirui, et al.
Publicado: (2018)

Molecular evolution of the human SRPX2 gene that causes brain disorders of the Rolandic and Sylvian speech areas
por: Royer, Barbara, et al.
Publicado: (2007)

Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene
por: Soteros, Breeanne M., et al.
Publicado: (2018)

Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro
por: Zhong, Yali, et al.
Publicado: (2015)

Notch1 Is a 5-Fluorouracil Resistant and Poor Survival Marker in Human Esophagus Squamous Cell Carcinomas
por: Liu, Jian, et al.
Publicado: (2013)

Pelota interacts with HAX1, EIF3G and SRPX and the resulting protein complexes are associated with the actin cytoskeleton
por: Burnicka-Turek, Ozanna, et al.
Publicado: (2010)

The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development
por: Cong, Qifei, et al.
Publicado: (2020)

MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
por: Li, Xiaoran, et al.
Publicado: (2016)

Correction: MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
por: Li, Xiaoran, et al.
Publicado: (2017)

Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition
por: Wang, Qi, et al.
Publicado: (2021)

Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition: Erratum
por: Wang, Qi, et al.
Publicado: (2022)

Nomogram to predict unfavorable outcome of endovascular thrombectomy for large ischemic core
por: Han, Nannan, et al.
Publicado: (2023)

A 4K score/MRI‐based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Potent and specific MTH1 inhibitors targeting gastric cancer
por: Zhou, Wenjuan, et al.
Publicado: (2019)

Correction: Potent and specific MTH1 inhibitors targeting gastric cancer
por: Zhou, Wenjuan, et al.
Publicado: (2020)

Nomogram to predict 3-month unfavorable outcome after thrombectomy for stroke
por: Zhang, Xiao-Guang, et al.
Publicado: (2022)

Microvascular dysfunction associated with unfavorable venous outflow in acute ischemic stroke patients
por: Li, Xiaoshuang, et al.
Publicado: (2023)

Subarachnoid extension and unfavorable outcomes in patients with supratentorial intracerebral hemorrhage
por: Wang, Jinjin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_upfh39q4sd341v8j5mv2hab9ot